Rhumbline Advisers Ocugen, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Ocugen, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 287,441 shares of OCGN stock, worth $227,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
287,441
Previous 301,218
4.57%
Holding current value
$227,078
Previous $466,000
39.06%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
78.3MCall Options Held
535KPut Options Held
523K-
Black Rock Inc. New York, NY17.9MShares$14.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.9MShares$13.4 Million0.0% of portfolio
-
State Street Corp Boston, MA15.8MShares$12.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.28MShares$4.96 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.94 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $171M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...